Rolf Reissbrodt

Title: Rolf Reissbrodt: Innovator in Pharmaceutical Research

Introduction

Rolf Reissbrodt is a notable inventor based in Wernigerode, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds with potential medical applications. With a total of 2 patents, his work focuses on synthetic catechol derivatives and their uses in combating bacterial infections.

Latest Patents

Rolf's latest patents include "Synthetic catechol derivatives, method for production and use thereof" and "Benzoxazinedione derivatives, method of producing them and uses thereof." The latter invention relates to new benzoxazinedione derivatives that can effectively act as siderophores against gram-negative bacterial strains, such as Pseudomonads and strains of E. coli and Salmonella. These compounds can transport antibiotics into bacterial cells, enhancing their antibacterial effects, especially against resistant strains. Additionally, they may serve as prodrug forms for iron chelating agents, making them suitable for treating diseases related to iron metabolism disorders.

Career Highlights

Rolf Reissbrodt is currently associated with Gruenenthal GmbH, where he continues to advance his research in pharmaceutical innovations. His work has implications not only in the pharmaceutical industry but also in agriculture, showcasing the versatility of his inventions.

Collaborations

Rolf has collaborated with notable colleagues, including Ute Moellmann and Lothar Heinisch, contributing to the collective advancement of their research projects.

Conclusion

Rolf Reissbrodt's innovative work in synthetic catechol derivatives and benzoxazinedione derivatives highlights his significant role in pharmaceutical research. His contributions are paving the way for new treatments against bacterial infections and disorders related to iron metabolism.